Literature DB >> 17554171

Improved crystallization of the coxsackievirus B3 RNA-dependent RNA polymerase.

Ilham Jabafi1, Barbara Selisko, Bruno Coutard, Armando M De Palma, Johan Neyts, Marie Pierre Egloff, Sacha Grisel, Karen Dalle, Valerie Campanacci, Silvia Spinelli, Christian Cambillau, Bruno Canard, Arnaud Gruez.   

Abstract

The Picornaviridae virus family contains a large number of human pathogens such as poliovirus, hepatitis A virus and rhinoviruses. Amongst the viruses belonging to the genus Enterovirus, several serotypes of coxsackievirus coexist for which neither vaccine nor therapy is available. Coxsackievirus B3 is involved in the development of acute myocarditis and dilated cardiomyopathy and is thought to be an important cause of sudden death in young adults. Here, the first crystal of a coxsackievirus RNA-dependent RNA polymerase is reported. Standard crystallization methods yielded crystals that were poorly suited to X-ray diffraction studies, with one axis being completely disordered. Crystallization was improved by testing crystallization solutions from commercial screens as additives. This approach yielded crystals that diffracted to 2.1 A resolution and that were suitable for structure determination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554171      PMCID: PMC2335076          DOI: 10.1107/S1744309107020416

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  14 in total

1.  A medium-throughput crystallization approach.

Authors:  Gerlind Sulzenbacher; Arnaud Gruez; Véronique Roig-Zamboni; Silvia Spinelli; Christel Valencia; Fabienne Pagot; Renaud Vincentelli; Christophe Bignon; Aurelia Salomoni; Sacha Grisel; Damien Maurin; Céline Huyghe; Kent Johansson; Alice Grassick; Alain Roussel; Yves Bourne; Sophie Perrier; Linda Miallau; Phillippe Cantau; Eric Blanc; Michel Genevois; Alain Grossi; André Zenatti; Valérie Campanacci; Christian Cambillau
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

Review 2.  Regulation of picornavirus gene expression.

Authors:  Kristin M Bedard; Bert L Semler
Journal:  Microbes Infect       Date:  2004-06       Impact factor: 2.700

3.  Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication.

Authors:  W Xiang; K S Harris; L Alexander; E Wimmer
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 4.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

Review 5.  Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes.

Authors:  A Kukreja; N K Maclaren
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

6.  Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Roivainen; M Knip; H Hyöty; P Kulmala; M Hiltunen; P Vähäsalo; T Hovi; H K Akerblom
Journal:  J Med Virol       Date:  1998-09       Impact factor: 2.327

7.  Can enteroviruses cause type 1 diabetes?

Authors:  Sisko Tauriainen; Kimmo Salminen; Heikki Hyöty
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

8.  A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis.

Authors:  A K Foulis; M A Farquharson; S O Cameron; M McGill; H Schönke; R Kandolf
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

Review 9.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 10.  The impact of protein characterization in structural proteomics.

Authors:  Arie Geerlof; J Brown; B Coutard; M P Egloff; F J Enguita; M J Fogg; R J C Gilbert; M R Groves; A Haouz; J E Nettleship; P Nordlund; R J Owens; M Ruff; S Sainsbury; D I Svergun; Matthias Wilmanns
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-09-19
View more
  4 in total

1.  Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.

Authors:  Rana Abdelnabi; Ana Theresa Silveira de Morais; Pieter Leyssen; Isabelle Imbert; Stéphanie Beaucourt; Hervé Blanc; Mathy Froeyen; Marco Vignuzzi; Bruno Canard; Johan Neyts; Leen Delang
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

2.  The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases.

Authors:  Arnaud Gruez; Barbara Selisko; Michael Roberts; Gérard Bricogne; Cécile Bussetta; Ilham Jabafi; Bruno Coutard; Armando M De Palma; Johan Neyts; Bruno Canard
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

3.  The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family.

Authors:  Lonneke van der Linden; Laia Vives-Adrián; Barbara Selisko; Cristina Ferrer-Orta; Xinran Liu; Kjerstin Lanke; Rachel Ulferts; Armando M De Palma; Federica Tanchis; Nesya Goris; David Lefebvre; Kris De Clercq; Pieter Leyssen; Céline Lacroix; Gerhard Pürstinger; Bruno Coutard; Bruno Canard; David D Boehr; Jamie J Arnold; Craig E Cameron; Nuria Verdaguer; Johan Neyts; Frank J M van Kuppeveld
Journal:  PLoS Pathog       Date:  2015-03-23       Impact factor: 6.823

4.  The VIZIER project: preparedness against pathogenic RNA viruses.

Authors:  B Coutard; A E Gorbalenya; E J Snijder; A M Leontovich; A Poupon; X De Lamballerie; R Charrel; E A Gould; S Gunther; H Norder; B Klempa; H Bourhy; J Rohayem; E L'hermite; P Nordlund; D I Stuart; R J Owens; J M Grimes; P A Tucker; M Bolognesi; A Mattevi; M Coll; T A Jones; J Aqvist; T Unge; R Hilgenfeld; G Bricogne; J Neyts; P La Colla; G Puerstinger; J P Gonzalez; E Leroy; C Cambillau; J L Romette; B Canard
Journal:  Antiviral Res       Date:  2007-11-29       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.